TM6SF2 and NCAN polymorphism impact on HCV in North African Egyptian patients
Youssef, S., Abd El Razek, E., Mahdy, R., Seif, S., El Kassas, M. (2018). TM6SF2 and NCAN polymorphism impact on HCV in North African Egyptian patients. EKB Journal Management System, 4(4), 401-409. doi: 10.21608/jbaar.2018.152435
Samar Samir Youssef; Eman Abd El Razek; Reem Ezzat Mahdy; Sameh Seif; Mohamed El Kassas. "TM6SF2 and NCAN polymorphism impact on HCV in North African Egyptian patients". EKB Journal Management System, 4, 4, 2018, 401-409. doi: 10.21608/jbaar.2018.152435
Youssef, S., Abd El Razek, E., Mahdy, R., Seif, S., El Kassas, M. (2018). 'TM6SF2 and NCAN polymorphism impact on HCV in North African Egyptian patients', EKB Journal Management System, 4(4), pp. 401-409. doi: 10.21608/jbaar.2018.152435
Youssef, S., Abd El Razek, E., Mahdy, R., Seif, S., El Kassas, M. TM6SF2 and NCAN polymorphism impact on HCV in North African Egyptian patients. EKB Journal Management System, 2018; 4(4): 401-409. doi: 10.21608/jbaar.2018.152435

TM6SF2 and NCAN polymorphism impact on HCV in North African Egyptian patients

Journal of Bioscience and Applied Research
Article 4, Volume 4, Issue 4, December 2018, Page 401-409  XML PDF (384.13 K)
Document Type: Original Article
DOI: 10.21608/jbaar.2018.152435
View on SCiNiTO View on SCiNiTO
Authors
Samar Samir Youssef email 1; Eman Abd El Razek1; Reem Ezzat Mahdy2; Sameh Seif3; Mohamed El Kassas4
1Department of Microbial Biotechnology, National Research Centre, Dokki, Egypt
2Assuit university hospital, Assuit, Egypt
3National Hepatology and Tropical Medicine Research Institute, Cairo, Egypt
4Endemic Medicine Department, Faculty of Medicine, Helwan University
Abstract
Background: TM6SF2 and NCAN are genes known to be related to fibrosis and steatosis but are not thoroughly investigated in the case of chronic Hepatitis C (HCV) in Egyptians.  Aim: This study is carried to investigate the role of TM6SF2 and NCAN in chronic HCV Egyptian patients. Methods: This retrospective study was carried out on 165 patients with chronic HCV who received treatment for it. Results: TM6SF2 showed statistical significance with viral load with a p-value of 0.02 but no statistical significance with fibrosis or activity. NCAN showed statistical significance with activity with a p-value of 0.011. Conclusion: this is the first work recording the prevalence of TM6SF2 (rs58542926) and NCAN (rs2228603) polymorphism in upper African HCV patients. TM6SF2 is not associated with fibrosis or activity in Egyptian patients infected with chronic hepatitis C but associated with high viral load. On the other side, NCAN is associated with severity of activity in the same studied group but no relation with the viral load. These results explain their additive effect exerted during HCV infection which should be further extensively studied.
Keywords
Transmembrane 6superfamily member 2 (TM6SF2); neurocan (NCAN); chronic HCV (CHC)
Statistics
Article View: 126
PDF Download: 147